CoChat

Can Factor V Leiden and prothrombin G20210A testing in women with recurrent pregnancy loss result in improved pregnancy outcomes?: Results from a targeted evidence-based review

Open access
Bradley, Linda A., Palomaki, Glenn E., Bienstock, Jessica, Varga, Elizabeth, Scott, Joan A. · 2012 · Genetics in Medicine

The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.

Abstract

Women with recurrent pregnancy loss are offered Factor V Leiden (F5) and/or prothrombin G20210A (F2) testing to identify candidates for anticoagulation to improve outcomes. A systematic literature review was performed to estimate test performance, effect sizes, and treatment effectiveness. Electronic searches were performed through April 2011, with review of references from included articles. English-language studies addressed analytic validity, clinical validity, and/or clinical utility and satisfied predefined inclusion criteria. Adequate evidence showed high analytic sensitivity and specificity for F5 and F2 testing. Evidence for clinical validity was adequate. The summary odds ratio for association of recurrent pregnancy loss with F5 in case-controlled studies was 2.02 (95% confidence interval, 1.60-2.55), with moderate heterogeneity and suggestion of publication bias. Longitudinal studies in women with recurrent pregnancy loss or unselected cohorts showed F5 carriers were more likely to have a subsequent loss than noncarriers (odds ratios: 1.93 and 2.03, respectively). Results for F2 testing were similar. For clinical utility, evidence was adequate that anticoagulation treatments were ineffective (except in antiphospholipid antibody syndrome) and had treatment-associated harms. The certainty of evidence is moderate (high, moderate, and low) that anticoagulation of women with recurrent pregnancy loss and F5/F2 variants would currently lead to net harms.

Overview

Integrity signals

Registry

Crossref · 10.1038/gim.0b013e31822e575b

Cites

136 of 136 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 136 references

Research works printed but not linked: 3

  1. Kujovich JL. Factor V Leiden thrombophilia. GENEReviews, 1999. http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book_gene&part_factor-v-leiden. Accessed 3 June 2009.
  2. Kujovich JL. Prothrombin thrombophilia. GENEReviews, 2006. http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book_gene&part_ptt. Accessed 3 June 2009.
  3. Phelan R (CEO, DNA Direct). Genetics and public policy center genetics perspectives on policy seminar, direct-to-consumer genetic testing: medicine in the marketplace. National Press Club: Washington, DC, 2005. http://www.dnapolicy.org/news.past.php?action_detail&past_event_id_18. Accessed 27 July 2010.

Cited by

See all 63

Metadata

Authors
Bradley, L. A., Palomaki, G. E., Bienstock, J., Varga, E., & Scott, J. A.
Affiliations
  • Brown University (US)
  • Johns Hopkins University (US)
  • Nationwide Children's Hospital (US)
Corresponding author
Bradley, Linda A.
Venue
Genetics in Medicine
Publisher
Elsevier BV
Published
2012-01
Volume
14
Issue
1
Pages
39-50
ISSN
1098-3600 (ISSN-L)
OpenAlex
W2015639441
Cited by
59
References
135
Citations by year
2026: 3 · 2025: 4 · 2024: 5 · 2023: 10 · 2022: 3 · 2021: 4 · 2020: 2 · 2019: 2 · 2018: 6 · 2017: 2 · 2016: 4 · 2015: 1 · 2014: 6 · 2013: 5 · 2012: 2
FWCI
0.71
Type
journal article
Language
en
Open access
Licence
Locations
  • Genetics in Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Pew Charitable Trusts
  • National Institutes of Health
Topics
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
  • Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
Keywords
factor V Leiden, prothrombin G20210A, recurrent pregnancy loss, anticoagulation, pregnancy outcomes, genetic testing, test performance, clinical validity, clinical utility, antiphospholipid syndrome, thrombophilia, treatment harms
MeSH terms
Abortion, Habitual, Factor V, Female, Genetic Testing, Humans, Pregnancy, Pregnancy Outcome, Prothrombin, Evidence-Based Medicine, Mutation, Missense

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Can Factor V Leiden and prothrombin G20210A testing in women with recurrent pregnancy loss result in improved pregnancy outcomes?: Results from a targeted evidence-based review. https://app.cochat.ai/papers/10.1038/gim.0b013e31822e575b
The paper
Bradley, L. A., Palomaki, G. E., Bienstock, J., Varga, E., & Scott, J. A. (2012). Can Factor V Leiden and prothrombin G20210A testing in women with recurrent pregnancy loss result in improved pregnancy outcomes?: Results from a targeted evidence-based review. Genetics in Medicine. https://doi.org/10.1038/gim.0b013e31822e575b

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.